The Southwest Lymphoma Workshop will be a virtual program to deliver live patient education programming during the COVID-19 pandemic. This program will still provide access to local lymphoma experts, and you can join online. Please continue to check this page for updates. For updates on digital programs, please ensure you are subscribed to receive emails from the Lymphoma Research Foundation (LRF).
VIRTUAL – Lymphoma Workshop: Understanding Lymphoma Basics and Current Treatment Options
DATE: Saturday, July 16, 2022
TIME: 9:00 AM MDT – 2:30 PM MDT
VIRTUAL PROGRAM – This is a virtual event, only accessible online. Access instructions will be provided before event date.
About The Workshop
The Lymphoma Research Foundation’s Lymphoma Workshop provides the latest information about lymphoma, current treatment options and support issues to members of the lymphoma community across the United States. The Southwest Lymphoma Workshop is the premier patient education and networking forum in the region.
Manali Kamdar, MD
University of Colorado
Javier L. Munoz, MD
Mayo Clinic, Arizona
Reasons To Attend
- Learn about your specific type of lymphoma, treatment options, clinical trials and novel concepts during the comprehensive disease-specific breakout sessions.
- Hear a variety of presentations and have your specific questions answered from our expert speaking faculty comprised of lymphoma specialists and patient support experts.
Program Agenda – Click Here
9:00 AM Explore vFairs Space and Exhibit Hall
9:30 AM Welcome and LRF Overview
LRF Overview – Sarah Quinlan, LRF
9:30 AM Overview of Lymphoma – Manali Kamdar, MD, University of Colorado
10:00 AM Update on COVID-19 – Sairah Ahmed, MD, MD Anderson Cancer Center
10:30 AM 30-minute Q&A with both speakers – Manali Kamdar, MD and Sairah Ahmed, MD
11:00 AM Networking Lounge and Exhibit Hall
11:15 AM Breakout Sessions: Disease-Specific
- Aggressive B-cell Non-Hodgkin Lymphomas: Newly Diagnosed – Michael Tees, MD, Colorado Blood Cancer Institute
- Aggressive B-cell Non-Hodgkin Lymphomas: Relapsed/Refractory – Boyu Hu, MD, University of Utah
- Aggressive T-Cell Lymphomas – Bradley Haverkos, MD, University of Colorado
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Newly Diagnosed – Michael Choi, MD, UC San Diego
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Relapsed/Refractory – John Burke, MD, Rocky Mountain Cancer Centers
- Cutaneous T-Cell Lymphomas – Madeleine Duvic, MD, MD Anderson Cancer Center
- Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL): Newly Diagnosed – Speaker TBA
- Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL): Relapsed/Refractory – Paolo Strati, MD, MD Anderson Cancer Center
- Hodgkin Lymphoma (HL) – Allison Rosenthal, DO, Mayo Clinic
- Mantle Cell Lymphoma (MCL): Newly Diagnosed – Abhijeet Kumar, MD, University of Arizona
- Mantle Cell Lymphoma (MCL): Relapsed/Refractory – Marc Hoffman, MD, University of Kansas
- Waldenström Macroglobulinemia (WM) – Jeffrey Matous, MD, Colorado Blood Cancer Institute
12:15 PM Networking Lounge and Exhibit Hall
12:30 PM Living with Lymphoma Breakouts
- Lymphoma Survivorship – Keri Halsema, NP, MSN, RN, University of Colorado
- Managing Treatment Side Effects – Sandy Kurtin, PhD, ANP-C, AOCN, The University of Arizona
- Oncofertility – Parenthood Options after Cancer – Laxmi A Kondapalli, MD, MSCE, Colorado Center for Reproductive Medicine
- Avoiding Financial Toxicity and Hardships – Joanna Morales, Esq., Triage Cancer
1:30 PM Immunotherapy and CAR T Cell Therapy – Javier Munoz, MD, Mayo Clinic
2:30 PM Workshop Concludes
Archive – (Go here if already registered.)
VIRTUAL PROGRAM – This is a virtual event, only accessible online. Access instructions will be provided after registration. This program will be accessible for up to a month following the event so please register even if you cannot attend the day of the live event.
For additional information, please contact a member of our Lymphoma Helpline staff at firstname.lastname@example.org or (800) 500-9976.
This program is for patients and survivors, caregivers and program supporters. If you are a pharmaceutical industry professional that is interested in attending but your company is not listed as a sponsor, please email email@example.com to learn more about sponsorship.
Disclaimer: The Lymphoma Research Foundation (LRF) is a national nonprofit organization based in the United States with educational programs and resources are intended for a US-based audience. These program and resources address available lymphoma treatments in the United States. and information on drug approvals by the US Food and Drug Administration.
For individuals outside of the US, LRF recommends the Lymphoma Coalition at www.lymphomacoalition.org. The Lymphoma Coalition is a global network of worldwide nonprofit/NGO lymphoma patient organizations with information appropriate for non US-based audiences.
This activity is supported by educational grants from:
National Presenting Supporter
National Platinum Supporter
National Gold Supporter
National Silver Supporters
National Bronze Supporters